Brian Slizgi, Director, Pharmaceutical & Life Sciences R&D Advisory, PwC

Brian is a Director with PwC’s Healthcare Advisory practice, where he focuses on Pharma Life Sciences research and development (R&D) strategy and operations.  With more than ten years of experience with the pharmaceutical industry, Brian’s recent focus has been on applying new digital technologies that that can foster increased patient safety, data quality, and operational efficiency. Brian is the author of a white paper on PwC’s perspective on risk-based monitoring and sits on the R&D Operations and the R&D Compliance communities. He also has experience in designing new operating models, outsourcing and performance management, and resource forecasting strategies.

Prior to PwC, Brian served in roles of increasing responsibility in Pharmaceutical R&D supporting the design and execution of Phase II-IV clinical trials.  Brian received his Master of Business Administration from the Paul Merage School of Business at the University of California, Irvine, where he graduated Beta Gamma Sigma and focused on healthcare management.  He also graduated with Honors from the University of California, Santa Barbara with a Bachelor of Science in Biochemistry and Molecular Biology.